DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | 0.0% | 98 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 98 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -66.7% | 98 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $3,000 | -25.0% | 98 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 98 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $4,000 | +33.3% | 98 | +108.5% | 0.00% | +50.0% |
| Q4 2020 | $3,000 | +50.0% | 47 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | – | 47 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $18,687,872 | 15.44% |
| Redmile Group, LLC | 5,582,105 | $86,243,522 | 3.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,218,638 | $80,627,957 | 1.80% |
| BRAIDWELL LP | 3,241,351 | $50,078,873 | 1.65% |
| Parkman Healthcare Partners LLC | 491,772 | $7,597,877 | 1.65% |
| Sunesis Advisors, LLC | 96,299 | $1,487,820 | 1.07% |
| ARMISTICE CAPITAL, LLC | 4,100,000 | $63,345,000 | 0.91% |
| Deep Track Capital, LP | 1,363,201 | $21,061,455 | 0.86% |
| AlphaCentric Advisors LLC | 72,500 | $1,120,125 | 0.77% |
| Ikarian Capital, LLC | 174,510 | $2,696,179 | 0.61% |